Bio-Connect

InVivoMAb anti-mouse CD19

BE0150
Bio X Cell
ApplicationsFlow Cytometry, Neutralisation/Blocking, Other Application
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse CD19
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, Neutralisation/Blocking, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    1D3
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2a
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Säwén P, Lang S, Mandal P, et al. Mitotic History Reveals Distinct Stem Cell Populations and Their Contributions to Hematopoiesis. Cell Rep. 2016,14(12):2809-18. doi: 10.1016/j.celrep.2016.02.073
    Read this paper
  • Bouffi C, Kartashov AV, Schollaert KL, et al. Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis. J Immunol. 2015,195(6):2683-95. doi: 10.4049/jimmunol.1500510
    Read this paper
  • Carmi Y, Spitzer MH, Linde IL, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015,521(7550):99-104. doi: 10.1038/nature14424
    Read this paper
  • Liu B, Lee JB, Chen CY, et al. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015,194(8):3583-93. doi: 10.4049/jimmunol.1400951
    Read this paper
  • Becker AM, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Exp Hematol. 2015,43(1):44-52.e1-3. doi: 10.1016/j.exphem.2014.10.001
    Read this paper
  • Dai M, Yip YY, Hellstrom I, et al. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015,21(5):1127-38. doi: 10.1158/1078-0432.CCR-14-1339
    Read this paper
  • De Obaldia ME, Bell JJ, Wang X, et al. T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1. Nat Immunol. 2013,14(12):1277-84. doi: 10.1038/ni.2760
    Read this paper
  • Guo Z, Cheng D, Xia Z, et al. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer. J Transl Med. 2013,11:215. doi: 10.1186/1479-5876-11-215
    Read this paper
  • Dai M, Wei H, Yip YY, et al. Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation. J Immunother. 2013,36(4):248-57. doi: 10.1097/CJI.0b013e3182943549
    Read this paper
  • Purtha WE, Swiecki M, Colonna M, et al. Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci U S A. 2012,109(15):E898-904. doi: 10.1073/pnas.1118155109
    Read this paper